KLP Kapitalforvaltning’s Revance Therapeutics, Inc. RVNC Stock Holding History

KLP Kapitalforvaltning’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-24,400	Closed	-$74.2K	–	2323
2024 Q4	$74.2K	Buy	+24,400	New	+$106K	﹤0.01%	2177

Other funds holding RVNC

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

KLP Kapitalforvaltning's RVNC Position: Q1 2025 in Review

KLP Kapitalforvaltning sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 24,400 shares — an estimated $74.2K sold.

KLP Kapitalforvaltning first reported a position in RVNC in Q4 2024 and held it in 1 quarter. The position peaked at $74.2K in Q4 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

KLP Kapitalforvaltning reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
KLP Kapitalforvaltning sold 24,400 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $74.2K.
KLP Kapitalforvaltning first reported a position in Revance Therapeutics, Inc. in Q4 2024 and held it in 1 quarter.
KLP Kapitalforvaltning's Revance Therapeutics, Inc. position peaked at $74.2K in Q4 2024.
1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2025, filed 6 May 2025.